Skip to main content
Log in

Reply to ‘Is it time to validate the prognostic role of F-18-FDG PET/CT scan in thymic epithelial tumors?’

  • Letter to the Editor
  • Published:
Annals of Nuclear Medicine Aims and scope Submit manuscript

The Original Article was published on 12 April 2014

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Seki N, Sakamoto S, Karube Y, Oyaizu T, Ishihama H, Chida M. 18F-fluorodeoxyglucose positron emission tomography for evaluation of thymic epithelial tumors: utility for World Health Organization classification and predicting recurrence-free survival. Ann Nucl Med. 2014. doi:10.1007/s12149-014-0804-2.

  2. Lococo F, Cesario A, Okami J, Cardillo G, Cavuto S, Tokunaga T, Apolone G, Margaritora S, Granone P. Role of combined 18F-FDG-PET/CT for predicting the WHO malignancy grade of thymic epithelial tumors: a multicenter analysis. Lung Cancer. 2013;82:245–51.

    Article  CAS  PubMed  Google Scholar 

  3. Adams MC, Turkington TG, Wilson JM, Wong TZ. A systematic review of the factors affecting accuracy of SUV measurements. Am J Roentgenol. 2010;195:310–20.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Masayuki Chida.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chida, M., Sakamoto, S. Reply to ‘Is it time to validate the prognostic role of F-18-FDG PET/CT scan in thymic epithelial tumors?’. Ann Nucl Med 28, 595–596 (2014). https://doi.org/10.1007/s12149-014-0848-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12149-014-0848-3

Keywords

Navigation